ID-Checker Technology for the Highly Selective Macroscale Delivery of Anticancer Agents to the Cancer Cells
Author:
Affiliation:
1. Biometrix Technology, Inc., 2-2 Bio Venture Plaza 56, Chuncheon 24232, South Korea
2. Institute of Applied Chemistry and Department of Chemistry, Hallym University, Chuncheon 200702, South Korea
Funder
National Research Foundation of Korea
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00646
Reference44 articles.
1. Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15
2. Exosomes: key players in cancer and potential therapeutic strategy
3. Controlled drug delivery vehicles for cancer treatment and their performance
4. Cardiovascular Complications of Cancer Therapy
5. What Is the Oncologic Risk of Stem Cell Treatment for Heart Disease?
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A trans-Ferulic acid based fluorescence “turn-on” chemosensor for aluminum (III) ions in live cells and environmental samples;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-09
2. The microtubule cytoskeleton: A validated target for the development of 2-Aryl-1H-benzo[d]imidazole derivatives as potential anticancer agents;Biomedicine & Pharmacotherapy;2024-02
3. Not all benzimidazole derivatives are microtubule destabilizing agents;Biomedicine & Pharmacotherapy;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3